Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 24, 2019 08:30 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Clobetasol Propionate Ointment USP, 0.05%

BUENA, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
January 02, 2019 08:30 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Gentamicin Sulfate Ointment USP, 0.1%

BUENA, N.J., Jan. 02, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
December 13, 2018 18:33 ET | Source: Teligent, Inc.

Teligent, Inc. Executes $120 Million Financing Agreement

BUENA, N.J., Dec. 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), (“Teligent” or the “Company”) announced today that on December 13, 2018 the Company entered into a definitive first lien...
November 16, 2018 17:15 ET | Source: Teligent, Inc.

Teligent, Inc. Receives Notification of Deficiency From NASDAQ Related to the Delayed Filing of Form 10-Q

BUENA, N.J., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), on November 13, 2018 received a standard notice from NASDAQ stating that, as a result of not having timely filed its...
November 13, 2018 16:15 ET | Source: Teligent, Inc.

Teligent, Inc. Announces $120 Million Financing Commitment From Ares

BUENA, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), (“Teligent” or the “Company”) announced today that the Company secured a financing commitment from funds managed by Ares...
November 13, 2018 16:15 ET | Source: Teligent, Inc.

Teligent, Inc. Announces Third Quarter 2018 Results

BUENA, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for...
November 12, 2018 08:30 ET | Source: Teligent, Inc.

Teligent, Inc. to Hold Conference Call for Third Quarter 2018 Results

BUENA, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm...
November 02, 2018 08:45 ET | Source: Teligent, Inc.

Teligent, Inc. to Present at Jefferies London Healthcare Conference on Wednesday November 14, 2018

BUENA, N.J., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at Jefferies London Healthcare...
October 24, 2018 08:45 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Desoximetasone Ointment USP 0.05%

BUENA, N.J., Oct. 24, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...
October 17, 2018 08:45 ET | Source: Teligent, Inc.

Teligent, Inc. Announces FDA Approval of Fluocinonide Cream USP, 0.05%

BUENA, N.J., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s...